Literature DB >> 20155458

Epigenetic regulation of the ERbeta gene on the estrogen signal transfection pathway in colon cancer cells.

Ronglin Zhai1, Guobin Wang, Kailin Cai, Kaixiong Tao, Fei Xu, Wanli Zhang, Zhiyong Wang.   

Abstract

We studied the regulatory effects of the estragen receptorbeta (ERbeta) gene on the downstream estrogen signal transfection pathway in colon cancer cells and the possible mechanisms involved. A human ERbeta gene recombinant expression plasmid, pEGFP-C1-ERbeta, was constructed and transfected into the Caco-2 colon cancer cell line, a line with low ERbeta gene expression. The expression of ERbeta mRNA and protein was detected 72 h after transfection. RT-PCR was used to examine the expression levels of the progesterone recepror (PR) gene containing the classic estrogen response element (ERE), the C-fos oncogene containing the AP-1 site (a non-classical ER binding site), the epigenetic modifying genes, such as Dnmt1, Dnmt3a, Dnmt3b, and histone methyltransferase (HMT), and the human mismatch repair gene hMLH1. Methylation-specific PCR was used to detect the changes in the methylated sites of the CpG islands in the promoters of the ERbeta, PR, and C-fos genes. The results indicated that the human ERbeta gene recombinant expression plasmid pEGFP-C1-ERbeta was successfully constructed and transfected into Caco-2 cells. As compared with the control group, the mRNA and protein expression of ERbeta gene was increased significantly 72 h after the transfection of pEGFP-C1-ERbeta into the Caco-2 cells. As compared with the control group, the mRNA expression of the PR, C-fos, Dnmt3a and Dnmt3b genes was increased significantly 72 h after the transfection of pEGFP-C1-ERbeta into the Caco-2 cells, but the mRNA expression of the Dnmt1, HMT, and hMLH1 genes decreased significantly (P<0.05). As compared with the control group, different degrees of demethylation occurred in the promoters of the ERbeta, progesterone receptor (PR), and C-fos oncogene 72 h after the transfection of pEGFP-C1-ERbeta into the Caco-2 cells. The methylation index of the estrogen signal transfection pathway in Caco-2 cells was decreased significantly following the expression restoration of ERbeta gene (P<0.05). It is concluded that the restoration or up-regulation of the ERbeta gene in Caco-2 cells may significantly activate the expression of the related target genes in the downstream estrogen signal transfection pathway and may result in the demethylation changes of the pathway. During the process, the expression level and activity of the epigenetic modifying genes and the human mismatch repair gene have changed simultaneously. The regulatory effect of the ERbeta gene on the estrogen signal transfection pathway to a certain extent partly involves demethylation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20155458     DOI: 10.1007/s11596-010-0112-6

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  27 in total

1.  Cloning of a novel receptor expressed in rat prostate and ovary.

Authors:  G G Kuiper; E Enmark; M Pelto-Huikko; S Nilsson; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  ER beta: identification and characterization of a novel human estrogen receptor.

Authors:  S Mosselman; J Polman; R Dijkema
Journal:  FEBS Lett       Date:  1996-08-19       Impact factor: 4.124

3.  Apoptotic effects of over-expressed estrogen receptor-beta on LoVo colon cancer cell is mediated by p53 signalings in a ligand-dependent manner.

Authors:  Hsi-Hsien Hsu; Sue-Fei Cheng; Cheng-Chung Wu; Chun-Hsien Chu; Yi-Jiun Weng; Chung-Sheng Lin; Shin-Da Lee; Hung-Chien Wu; Chih-Yang Huang; Wei-Wen Kuo
Journal:  Chin J Physiol       Date:  2006-04-30       Impact factor: 1.764

4.  Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis.

Authors:  F Grodstein; P A Newcomb; M J Stampfer
Journal:  Am J Med       Date:  1999-05       Impact factor: 4.965

Review 5.  Estrogen receptor interaction with estrogen response elements.

Authors:  C M Klinge
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

Review 6.  Estrogens, BRCA1, and breast cancer.

Authors:  L Hilakivi-Clarke
Journal:  Cancer Res       Date:  2000-09-15       Impact factor: 12.701

Review 7.  Mechanisms of estrogen action.

Authors:  S Nilsson; S Mäkelä; E Treuter; M Tujague; J Thomsen; G Andersson; E Enmark; K Pettersson; M Warner; J A Gustafsson
Journal:  Physiol Rev       Date:  2001-10       Impact factor: 37.312

Review 8.  Breast cancer, estrogen receptor and ligands.

Authors:  Zhenlin Bai; Ronald Gust
Journal:  Arch Pharm (Weinheim)       Date:  2009-03       Impact factor: 3.751

9.  Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation.

Authors:  P A Konstantinopoulos; A Kominea; G Vandoros; G P Sykiotis; P Andricopoulos; I Varakis; G Sotiropoulou-Bonikou; A G Papavassiliou
Journal:  Eur J Cancer       Date:  2003-06       Impact factor: 9.162

10.  Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.

Authors:  Aejaz Sayeed; Santhi D Konduri; Wensheng Liu; Sanjay Bansal; Fengzhi Li; Gokul M Das
Journal:  Cancer Res       Date:  2007-08-15       Impact factor: 12.701

View more
  2 in total

1.  Estrogen concentration and estrogen receptor-β expression in postmenopausal colon cancer considering patient/tumor background.

Authors:  Naoko Honma; Tomio Arai; Yoko Matsuda; Yosuke Fukunaga; Yuri Akishima-Fukasawa; Noriko Yamamoto; Hiroshi Kawachi; Yuichi Ishikawa; Kengo Takeuchi; Tetuo Mikami
Journal:  J Cancer Res Clin Oncol       Date:  2022-01-15       Impact factor: 4.322

Review 2.  The many faces of estrogen signaling.

Authors:  Peter Vrtačnik; Barbara Ostanek; Simona Mencej-Bedrač; Janja Marc
Journal:  Biochem Med (Zagreb)       Date:  2014-10-15       Impact factor: 2.313

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.